Ask AI

Clinical Case Files: Following the Metabolic Clues in Obesity and MASLD

Connections among obesity, metabolic dysfunction–associated steatotic liver disease (MASLD), and cardiovascular disease are becoming more evident, and healthcare professionals increasingly face the task of optimizing care for people with obesity and MASLD. Access an expert-written ClinicalThought commentary, downloadable slides, and an on-demand webcast for current evidence on the connections among these diseases, recommended screening and risk stratification approaches for timely recognition of MASLD and metabolic dysfunction–associated steatohepatitis, and the latest efficacy and safety data for new and emerging therapies.

Share

Program Content

Events

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Supporters

This activity is supported by Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc.